| Literature DB >> 33153453 |
Ulla Plenge1, Romy Parker2, Shamiela Davids3, Gareth L Davies4, Zahnne Fullerton5, Lindsay Gray6, Penelope Groenewald7, Refqah Isaacs8, Ntambue Kauta9, Frederik M Louw10, Andile Mazibuko11, David M North12, Marc Nortje13, Glen M Nunes14, Neo Pebane15, Chantal Rajah16, John Roos17, Paul Ryan18, Winlecia V September19, Heidi Shanahan20, Ruth E Siebritz21, Rian W Smit22, Simon Sombili23, Alexandra Torborg24, Johan F van der Merwe25, Nico van der Westhuizen26, Bruce Biccard2.
Abstract
BACKGROUND: Encouraged by the widespread adoption of enhanced recovery protocols (ERPs) for elective total hip and knee arthroplasty (THA/TKA) in high-income countries, our nationwide multidisciplinary research group first performed a Delphi study to establish the framework for a unified ERP for THA/TKA in South Africa. The objectives of this second phase of changing practice were to document quality of patient recovery, record patient characteristics and audit standard perioperative practice.Entities:
Keywords: DAH30; Enhanced recovery protocols; Low-and middle-income countries; Perioperative arthroplasty practice; Quality of recovery; South Africa; Total hip arthroplasty; Total knee arthroplasty
Mesh:
Year: 2020 PMID: 33153453 PMCID: PMC7643442 DOI: 10.1186/s12891-020-03752-x
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Flowchart of perioperative data capture. * TUG test was performed on day two for patients discharged before day three. If day three after surgery was on a weekend and the physiotherapist was not available to perform the test, patients would have their TUG tests on the first coming weekday i.e. day four or five after surgery
Fig. 2Flow diagram of the study cohort. n = patients
Baseline characteristics of total hip and knee arthroplasty patients in nine hospitals
| Patient characteristics | Whole cohort ( | DRHs ( | TCHs ( | |
|---|---|---|---|---|
| 89 (47.8)/97 (52.2) | 29 (50.9)/28 (49.1) | 60 (46.5)/69 (53.5) | 0.6 | |
| 127 (68.3) | 36 (63.2) | 91 (70.5) | 0.3 | |
| 50 (26.9) | 10 (17.5) | 40 (31.0) | 0.06 | |
| 15 (8.1) | 3 (5.3) | 12 (9.3) | 0.6 | |
| 8 (4.3) | 3 (5.3) | 5 (3.9) | 0.7 | |
| 62 (55–69) | 62 (55–69) | 63 (54–71) | 0.6 | |
| None | ||||
| 24 (12.9) | 7 (12.3) | 17 (13.2) | 0.9 | |
| 8 (4.3) | 4 (7.0) | 4 (3.1) | 0.3 | |
| 114 (62.0) | 30 (52.6) | 84 (66.1) | 0.08 | |
| 107 (58.2) | 29 (50.9) | 78 (61.4) | 0.2 | |
| None | ||||
| 7 (3.8) | 2 (3.5) | 5 (3.9) | 1.0 | |
| 40 (21.5) | 9 (15.8) | 31 (24.0) | 0.2 |
Data are n (%) or median (IQR)
aAmerican Society of Anesthesiologists Physical Status (ASA-PS) III
bFunctional pain in joint to be operated
cFemale Hgb < 12 g/dl and male Hgb < 13 g/dl
Please see the Abbreviations section for explanation of the acronyms and Supplementary data, Table S2 for definitions of patient characteristics
Thirty-day complication rate after total hip and knee arthroplasty in nine hospitals
| 30-day postoperative complications | Whole cohort ( | DRHs ( | TCHs ( | |
|---|---|---|---|---|
| 12 (6.5) | 1 (1.8) | 11 (8.5) | 0.1 | |
| | 5 (2.7) | 1 (1.8) | 4 (3.1) | 1.0 |
| | 1 (0.5) | None | 1 (0.8) | 1.0 |
| | 1 (0.5) | None | 1 (0.8) | 1.0 |
| | 1 (0.5) | None | 1 (0.8) | 1.0 |
| | 5 (2.7) | None | 5 (3.9) | 0.3 |
| | 3 (1.6) | None | 3 (2.3) | 0.6 |
| | 2 (1.1) | None | 2 (1.6) | 1.0 |
Data are n (%)
1 patient had 2 postoperative complications (in-hospital wound oozing and readmission with pulmonary emboli)
aFor example wound oozing, wound haematoma
bOnly total hip arthroplasties
cOnly total knee arthroplasties
Please see the Abbreviations section for explanation of the acronyms and Supplementary data, Table S1 for definitions of postoperative complications
Fig. 3Distribution of DAH30. a DAH30 for District and Regional Hospitals (n = 57). b DAH30 for Tertiary and Central Hospitals (n = 129). c DAH30 for the full patient cohort (n = 186). Y-axis = Number of patients, X-axis = Days alive and at home up to 30 days after surgery (DAH30). The smoothing line represents normal distribution
Perioperative practice for total hip and knee arthroplasty patients in nine hospitals
| Perioperative practice | Whole cohort ( | DRHs ( | TCHs | |
|---|---|---|---|---|
| | 67 (36.2) | 13 (22.8) | 54 (42.2) | 0.01 |
| | 74 (40.0) | 25 (43.9) | 49 (38.3) | 0.5 |
| | 55 (30.1) | 12 (21.1) | 43 (34.1) | 0.07 |
| | 125 (67.9) | 31 (54.4) | 94 (74.0) | 0.01 |
| | 37 (20.0) | 8 (14.0) | 29 (22.7) | 0.2 |
| | 42 (23.1) | 18 (31.6) | 24 (19.2) | 0.07 |
| | 4/40 (10) | None | 4 (12.9) | 0.6 |
| | 90 (75–106) | 91 (80–118) | 90 (71–106) | 0.6 |
| | 105 (85–125) | 113 (97–126) | 100 (73–125) | 0.06 |
| | 185 (100) | 57 (100) | 128 (100) | |
| | 30 (36.1) | 15 (60.0) | 15 (25.9) | 0.003 |
| | 62 (66.7) | 26 (92.9) | 36 (55.4) | < 0.001 |
| | 121 (65.1) | 47 (82.5) | 74 (57.4) | 0.001 |
| | 178 (96.2) | 57 (100) | 121 (94.5) | 0.1 |
| | 1 (0.5) | None | 1 (0.8) | 1.0 |
| | 179 (97.3) | 55 (96.5) | 124 (97.6) | 0.6 |
| | 69 (38.1) | 36 (65.5) | 33 (26.2) | < 0.001 |
| | 29 (16.0) | 14 (25.5) | 15 (11.9) | 0.02 |
| | 149 (85.1) | 46 (85.2) | 103 (85.1) | 1.0 |
| | 103 (57.5) | 32 (59.3) | 71 (56.8) | 0.8 |
| | 82 (45.3) | 23 (41.8) | 59 (46.8) | 0.5 |
Data are n (%) or median (IQR)
a = 40 patients (21.5%) presented with anaemia, 4 (10.0%) had initiated medical treatment to increase haemoglobin concentration; b = drugs administered since conclusion of surgery
Please see the Abbreviations section for explanation of the acronyms and Supplementary data, Tables S2-S5 for definitions of perioperative interventions and Table S8 for reporting of missing data